Clinical Trial Update: ActaVisc and ActaVisc Mx Intra-articular Injection for Pain Associated With Osteoarthritis in the Knee [NA]

View source ↗

Summary

The ActaVisc and ActaVisc Mx intra-articular injections trial for knee osteoarthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• ActaVisc
• ActaVisc Mx

Snippet

Sponsor: Carbylan Therapeutics, Inc. | Conditions: Osteoarthritis | NA | Status: TERMINATED